在慢性高血压环境下,对大鼠上腺髓刺激-分泌合的适应性重塑
Vincent Paillé1,2, Joohee Park1, Bertrand Toutain1
1Univ Angers, INSERM, CNRS, MITOVASC, Équipe CARME, SFR ICAT, F-49000 Angers, France.
Cellular and molecular life sciences : CMLS
|December 26, 2024
概括
高血压重塑上腺髓,在持续刺激过程中降低了儿科胺分泌效率. 这种适应机制可以防止过度的激素释放和相关的血压损伤.
科学领域:
- 神经内分泌学神经内分泌学
- 心血管生理学心血管生理学
背景情况:
- 慢性高血压会破坏器官功能和身体平衡.
- 上腺髓,至关重要的血压调节通过分泌catecholamine,是理解保护机制的关键目标.
研究的目的:
- 为了研究长期高血压的反应,上腺髓的甲醇胺分泌中的适应性变化.
- 阐明这些适应的基础是细胞和组织机制.
主要方法:
- 在自发高血压大鼠的急性上腺切片上使用电生理学技术.
- катехоламин分泌的测定. 测试. 测试. 测试.
- 计算的克罗马芬细胞建模.
- 分析电压关闭的离子通道表达.
主要成果:
- 克罗马芬细胞刺激-分泌合被重塑,导致在持续的胆固醇刺激下减少分泌功能.
- 在持续的电刺激过程中观察到氨酸细胞兴奋性下降,由计算模型和离子通道表达的变化支持.
- 脊柱神经-克罗马芬细胞突触和克罗马芬细胞之间的间隙结沟通中的胆固醇传递受损.
结论:
- 高血压的上腺髓通过在持续刺激期间降低甲基荷胺释放能力来开发适应性屏蔽机制.
- 这种适应性可以防止过度catecholamine分泌和相关血压升高的有害影响.
相关概念视频
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302
Hormonal Regulation of Blood Pressure
2.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.2K
Hormonal Regulation
32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Neural Regulation of Blood Pressure
2.5K
The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
2.5K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
376
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
376
Hypertension and Regulation of Blood Pressure
1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K


